Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Issued Notice of Allowance on microRNA Patent Application

Premium

Rosetta Genomics said this week that it has received notice that the US Patent and Trademark Office will allow claims in a patent application related to microRNA-378 as a specific miRNA sequence, as well as sequence variants.

“The allowed claims are directed to novel technologies that can be used for detecting and profiling microRNAs, and have application in the use of microRNA-378 as diagnostic biomarkers and therapeutics targets,” the company said, noting that the miRNA is a key part of its MiRview Mets line of cancer diagnostics.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.